Inhibition of Lnk in mouse induced pluripotent stem cells promotes hematopoietic cell generation

Stem Cells and Development

Volumn 21, Issue 18, 2012, Pages 3381-3390

  Tashiro, Katsuhisa ^a   Omori, Miyuki ^a,b   Kawabata, Kenji ^a,b   Hirata, Nobue ^a   Yamaguchi, Tomoko ^a   Sakurai, Fuminori ^b   Takaki, Satoshi ^c   Mizuguchi, Hiroyuki ^a,b  

^a NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; ADAPTOR PROTEIN LNK; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR TAL1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN FUNCTION;

ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HEMATOPOIETIC STEM CELLS; INDUCED PLURIPOTENT STEM CELLS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; THROMBOPOIETIN; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

ADENOVIRIDAE; IPS;

EID: 84870783700     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0100     Document Type: Article

References (49)

1. Evans MJ and MH Kaufman. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature 292:154-156.
2. Thomson JA, J Itskovitz-Eldor, SS Shapiro, MA Waknitz, JJ Swiergiel, VS Marshall and JM Jones. (1998). Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147.
3. Takahashi K and S Yamanaka. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676.
4. Takahashi K, K Tanabe, M Ohnuki, M Narita, T Ichisaka, K Tomoda and S Yamanaka. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872.
5. Nakano T, H Kodama and T Honjo. (1994). Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265:1098-1101.
6. Chadwick K, L Wang, L Li, P Menendez, B Murdoch, A Rouleau and M Bhatia. (2003). Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood 102:906-915.
7. Schmitt TM, RF de Pooter, MA Gronski, SK Cho, PS Ohashi and JC Zuniga-Pflucker. (2004). Induction of T cell development and establishment of T cell competence from embryonic stem cells differentiated in vitro. Nat Immunol 5: 410-417.
8. Hiroyama T, K Miharada, K Sudo, I Danjo, N Aoki and Y Nakamura. (2008). Establishment of mouse embryonic stem cell-derived erythroid progenitor cell lines able to produce functional red blood cells. PLoS One 3:e1544.
9. Choi KD, J Yu, K Smuga-Otto, G Salvagiotto,WRehrauer, M Vodyanik, J Thomson and I Slukvin. (2009). Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 27:559-567.
10. Lei F, R Haque, L Weiler, KE Vrana and J Song. (2009). T lineage differentiation from induced pluripotent stem cells. Cell Immunol 260:1-5.
11. Benezra R, RL Davis, D Lockshon, DL Turner and H Weintraub. (1990). The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61:49-59.
12. Hong SH, JH Lee, JB Lee, J Ji and M Bhatia. (2011). ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis. J Cell Sci 124:1445-1452.
13. Takaki S, H Morita, Y Tezuka and K Takatsu. (2002). Enhanced hematopoiesis by hematopoietic progenitor cellslacking intracellular adaptor protein, Lnk. J Exp Med 195: 151-160.
14. Velazquez L, AM Cheng, HE Fleming, C Furlonger, S Vesely, A Bernstein, CJ Paige and T Pawson. (2002). Cytokine signaling and hematopoietic homeostasis are disrupted in Lnk-deficient mice. J Exp Med 195:1599-1611.
15. Ema H, K Sudo, J Seita, A Matsubara, Y Morita, M Osawa, K Takatsu, S Takaki and H Nakauchi. (2005). Quantification of self-renewal capacity in single hematopoietic stem cells from normal and Lnk-deficient mice. Dev Cell 8:907-914.
16. Seita J, H Ema, J Ooehara, S Yamazaki, Y Tadokoro, A Yamasaki, K Eto, S Takaki, K Takatsu and H Nakauchi. (2007). Lnk negatively regulates self-renewal of hematopoietic stem cells by modifying thrombopoietin-mediated signal transduction. Proc Natl Acad Sci U S A 104:2349-2354.
17. Kwon SM, T Suzuki, A Kawamoto, M Ii, M Eguchi, H Akimaru, M Wada, T Matsumoto, H Masuda, et al. (2009). Pivotal role of lnk adaptor protein in endothelial progenitor cell biology for vascular regeneration. Circ Res 104:969-977.
18. Yokota Y. (2001). Id and development. Oncogene 20:8290-8298.
19. Takizawa H, C Kubo-Akashi, I Nobuhisa, SM Kwon, M Iseki, T Taga, K Takatsu and S Takaki. (2006). Enhanced engraftment of hematopoietic stem/progenitor cells by the transient inhibition of an adaptor protein, Lnk. Blood 107: 2968-2975.
20. Mizuguchi H and MA Kay. (1998). Efficient construction of a recombinant adenovirus vector by an improved in vitro ligation method. Hum Gene Ther 9:2577-2583.
21. Mizuguchi H and MA Kay. (1999). A simple method for constructing E1-and E1/E4-deleted recombinant adenoviral vectors. Hum Gene Ther 10:2013-2017.
22. Kawabata K, F Sakurai, T Yamaguchi, T Hayakawa and H Mizuguchi. (2005). Efficient gene transfer into mouse embryonic stem cells with adenovirus vectors. Mol Ther 12: 547-554.
23. Niwa H, K Yamamura and J Miyazaki. (1991). Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 108:193-199.
24. Tashiro K, K Kawabata, H Sakurai, S Kurachi, F Sakurai, K Yamanishi and H Mizuguchi. (2008). Efficient adenovirus vector-mediated PPAR gamma gene transfer into mouse embryoid bodies promotes adipocyte differentiation. J Gene Med 10:498-507.
25. Tashiro K, K Kawabata, M Omori, T Yamaguchi, F Sakurai, K Katayama, T Hayakawa and H Mizuguchi. (2012). Promotion of hematopoietic differentiation from mouse induced pluripotent stem cells by transient HoxB4 transduction. Stem Cell Res 8:300-311.
26. Maizel JV, Jr., DO White and MD Scharff. (1968). The polypeptides of adenovirus. I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12. Virology 36:115-125.
27. Okita K, T Ichisaka and S Yamanaka. (2007). Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317.
28. Tashiro K, M Inamura, K Kawabata, F Sakurai, K Yamanishi, T Hayakawa and H Mizuguchi. (2009). Efficient adipocyte and osteoblast differentiation from mouse induced pluripotent stem cells by adenoviral transduction. Stem Cells 27:1802-1811.
29. Nishikawa SI, S Nishikawa, M Hirashima, N Matsuyoshi and H Kodama. (1998). Progressive lineage analysis by cell sorting and culture identifies FLK1 + VE-cadherin + cells at a diverging point of endothelial and hemopoietic lineages. Development 125:1747-1757.
30. Yamashita J, H Itoh, M Hirashima, M Ogawa, S Nishikawa, T Yurugi, M Naito and K Nakao. (2000). Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 408:92-96.
31. Huber TL, V Kouskoff, HJ Fehling, J Palis and G Keller. (2004). Haemangioblast commitment is initiated in the primitive streak of the mouse embryo. Nature 432:625-630.
32. Wilson NK, SD Foster, X Wang, K Knezevic, J Schutte, P Kaimakis, PM Chilarska, S Kinston, WH Ouwehand et al. (2010). Combinatorial transcriptional control in blood stem/ progenitor cells: genome-wide analysis of ten major transcriptional regulators. Cell Stem Cell 7:532-544.
33. Robb L, NJ Elwood, AG Elefanty, F Kontgen, R Li, LD Barnett and CG Begley. (1996). The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. EMBO J 15:4123-4129.
34. D'Souza SL, AG Elefanty and G Keller. (2005). SCL/Tal-1 is essential for hematopoietic commitment of the hemangioblast but not for its development. Blood 105:3862-3870.
35. Inamura M, K Kawabata, K Takayama, K Tashiro, F Sakurai, K Katayama, M Toyoda, H Akutsu, Y Miyagawa, et al. (2011). Efficient generation of hepatoblasts from human ES cells and iPS cells by transient overexpression of homeobox gene HEX. Mol Ther 19:400-407.
36. Takayama K, M Inamura, K Kawabata, K Tashiro, K Katayama, F Sakurai, T Hayakawa, Furue MK, H Mizuguchi. (2011). Efficient and directive generation of two distinct endoderm lineages from human ESCs and iPSCs by differentiation stage-specific SOX17 transduction. PLoS One 6: e21780.
37. Takayama K, M Inamura, K Kawabata, K Katayama, M Higuchi, K Tashiro, A Nonaka, F Sakurai, T Hayakawa, F Kusudaurue M and H Mizuguchi. (2012). Efficient generation of functional hepatocytes from human embryonic stem cells and induced pluripotent stem cells by HNF4alpha transduction. Mol Ther 20:127-137.
38. Nobuhisa I, M Takizawa, S Takaki, H Inoue, K Okita, M Ueno, K Takatsu and T Taga. (2003). Regulation of hematopoietic development in the aorta-gonad-mesonephros region mediated by Lnk adaptor protein. Mol Cell Biol 23: 8486-8494.
39. Matsumoto K, T Isagawa, T Nishimura, T Ogaeri, K Eto, S Miyazaki, J Miyazaki, H Aburatani, H Nakauchi and H Ema. (2009). Stepwise development of hematopoietic stem cells from embryonic stem cells. PLoS One 4:e4820.
40. Tong W and HF Lodish. (2004). Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis. J Exp Med 200:569-580.
41. Gueller S, HS Goodridge, B Niebuhr, H Xing, M Koren Michowitz, H Serve, DM Underhill, CH Brandts and HP Koeffler. (2010). Adaptor protein Lnk inhibits c-Fms-mediated macrophage function. J Leukoc Biol 88:699-706.
42. Geest CR and PJ Coffer. (2009). MAPK signaling pathways in the regulation of hematopoiesis. J Leukoc Biol 86:237-250.
43. Martelli AM, C Evangelisti, F Chiarini, C Grimaldi, A Cappellini, A Ognibene and JA McCubrey. (2010). The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis. Biochim Biophys Acta 1803: 991-1002.
44. Dravid G, Y Zhu, J Scholes, D Evseenko and GM Crooks. (2011). Dysregulated gene expression during hematopoieticdifferentiation from human embryonic stem cells. Mol Ther 19:768-781.
45. Bersenev A, C Wu, J Balcerek, J Jing, M Kundu, GA Blobel, KR Chikwava and W Tong. (2010). Lnk constrains myeloproliferative diseases in mice. J Clin Invest 120:2058-2069.
46. Oh ST, EF Simonds, C Jones, MB Hale, Y Goltsev, KD Gibbs, Jr., JD Merker, JL Zehnder, GP Nolan and J Gotlib. (2010). Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms. Blood 116:988-992.
47. Kawabata K, F Sakurai, N Koizumi, T Hayakawa and H Mizuguchi. (2006). Adenovirus vector-mediated gene transfer into stem cells. Mol Pharm 3:95-103.
48. Takaki S, K Sauer, BM Iritani, S Chien, Y Ebihara, K Tsuji, K Takatsu and RM Perlmutter. (2000). Control of B cell production by the adaptor protein lnk. Definition Of a conserved family of signal-modulating proteins. Immunity 13:599-609.
49. Tong W, J Zhang and HF Lodish. (2005). Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood 105:4604-4612.